Development and validation of a liquid chromatography-tandem mass spectrometry analytical method for the therapeutic drug monitoring of eight novel anticancer drugs-Reference-Cited by-同舟云学术

Development and validation of a liquid chromatography-tandem mass spectrometry analytical method for the therapeutic drug monitoring of eight novel anticancer drugs

Published:2017-12-19 Issue:4 Volume:32 Page:e4147
ISSN:0269-3879
Container-title:Biomedical Chromatography
language:en
Short-container-title:Biomedical Chromatography

Author:

Herbrink M.¹^ORCID,de Vries N.¹,Rosing H.¹,Huitema A. D. R.¹²,Nuijen B.¹,Schellens J. H. M.¹³,Beijnen J. H.¹³

Affiliation:

1. Department of Pharmacy and Pharmacology; The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital and MC Slotervaart; Amsterdam The Netherlands

2. Department of Clinical Pharmacy; University Medical Center Utrecht; Utrecht The Netherlands

3. Division of Pharmacoepidemiology and Clinical Pharmacology, Science Faculty, Utrecht Institute for Pharmaceutical Sciences; Utrecht University; Utrecht The Netherlands

Publisher

Wiley

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,General Medicine,Biochemistry,Analytical Chemistry

Reference28 articles.

1. European Medicines Agency 2015 Assessment Report Zykadia (EPAR) http://www.ema.europa.eu/ema/

2. European Medicines Agency, & Use, Committee for Medicinal Products for Human Use (CHMP). 2011 Guidelines on Bioanalytical Method Validation http://www.ema.europa.eu/ema/

3. Dose selection, pharmacokinetics, and pharmacodynamics of BRAF inhibitor dabrafenib (GSK2118436);Falchook;Clinical Cancer Research,2014

4. Evidence for therapeutic drug monitoring of targeted anticancer therapies;Gao;Journal of Clinical Oncology,2012

5. Quantification of 11 therapeutic kinase inhibitors in human plasma for therapeutic drug monitoring using liquid chromatography coupled with tandem mass spectrometry;Herbrink;Therapeutic Drug Monitoring,2016

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simultaneous determination of unecritinib (TQ-B3101) and its active metabolite crizotinib in rat plasma by LC-MS/MS：An application to pharmacokinetic studies;Journal of Pharmaceutical and Biomedical Analysis;2024-08

2. A new validated high‐performance liquid chromatography method for the determination of regorafenib in rat plasma: Application for pharmacokinetic study;SEPARATION SCIENCE PLUS;2024-03-10

3. Are novel oral oncolytics underdosed in obese patients?;Cancer Chemotherapy and Pharmacology;2023-10-31

4. Development and validation of an LC–MS/MS method to measure the BRAF inhibitors dabrafenib and encorafenib quantitatively and four major metabolites semi-quantitatively in human plasma;Journal of Pharmaceutical and Biomedical Analysis;2023-09

5. Clinical Relevance of High Plasma Trough Levels of the Kinase Inhibitors Crizotinib, Alectinib, Osimertinib, Dabrafenib, and Trametinib in NSCLC Patients;Therapeutic Drug Monitoring;2023-06-20